↑ トップへ　← 戻る

Target Gene/Pathway（薬物標的遺伝子／パスウェイリスト）💬 Info on mouse-over

e.g. Sirolimus, アダリムマブ, MAP2K

ABCDEFGH I JKLMNOPQRSTUVWXYZother

123 / 286 pathways

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related		 KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Acute myeloid leukemia 💬
 1件: RARA 💬 D01418 💬 Tamibarotene 2件: 26, 96 💬
2 Adipocytokine signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
3 African trypanosomiasis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
4 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
5 Alanine, aspartate and glutamate metabolism 💬
 4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
6 Aldosterone synthesis and secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
7 Allograft rejection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
8 Alzheimer disease 💬
 3件: CHRM1, CHRM3, CHRM5 💬 D00481 💬 Propantheline 1件: 26 💬
9 Alzheimer disease 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
10 Alzheimer disease 💬
 1件: PSMB5 💬 D03150 💬 Bortezomib 15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
11 Alzheimer disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
12 Alzheimer disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 3件: 26, 34, 331 💬
13 Alzheimer disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 3件: 26, 34, 331 💬
14 Amoebiasis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
15 Amphetamine addiction 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
16 Amyotrophic lateral sclerosis 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
17 Amyotrophic lateral sclerosis 💬
 1件: PSMB5 💬 D03150 💬 Bortezomib 15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
18 Amyotrophic lateral sclerosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
19 Amyotrophic lateral sclerosis 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 3件: 26, 34, 331 💬
20 Amyotrophic lateral sclerosis 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 3件: 26, 34, 331 💬
21 Antifolate resistance 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
22 Antigen processing and presentation 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
23 Apoptosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
24 Asthma 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
25 Axon guidance 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
26 B cell receptor signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
27 beta-Alanine metabolism 💬
 3件: ABAT, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
28 Butanoate metabolism 💬
 4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
29 C-type lectin receptor signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
30 C-type lectin receptor signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
31 Calcium signaling pathway 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
32 Calcium signaling pathway 💬
 4件: CHRM1, CHRM2, CHRM3, CHRM5 💬 D00481 💬 Propantheline 1件: 26 💬
33 Calcium signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
34 cAMP signaling pathway 💬
 2件: CHRM1, CHRM2 💬 D00481 💬 Propantheline 1件: 26 💬
35 Cell adhesion molecules 💬
 1件: PDCD1 💬 D10316 💬 Nivolumab 12件: 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
36 Cellular senescence 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
37 cGMP-PKG signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
38 Chagas disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
39 Chemokine signaling pathway 💬
 1件: CCR4 💬 D09761 💬 Mogamulizumab 1件: 26 💬
40 Cholinergic synapse 💬
 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 D00481 💬 Propantheline 1件: 26 💬
41 Circadian entrainment 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
42 Coronavirus disease - COVID-19 💬
 2件: IFNAR1, IFNAR2 💬 D03305 💬 Interferon alfa 6件: 13, 25, 26, 28, 56, 96 💬
43 Coronavirus disease - COVID-19 💬
 2件: IFNAR1, IFNAR2 💬 D04554 💬 Interferon beta-1a 4件: 13, 26, 96, 97 💬
44 Coronavirus disease - COVID-19 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
45 Cortisol synthesis and secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
46 Cushing syndrome 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
47 Cytokine-cytokine receptor interaction 💬
 1件: CCR4 💬 D09761 💬 Mogamulizumab 1件: 26 💬
48 Cytokine-cytokine receptor interaction 💬
 1件: CSF3R 💬 D03235 💬 Filgrastim 33件:  2 ,  6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
49 Cytokine-cytokine receptor interaction 💬
 2件: IFNAR1, IFNAR2 💬 D03305 💬 Interferon alfa 6件: 13, 25, 26, 28, 56, 96 💬
50 Cytokine-cytokine receptor interaction 💬
 2件: IFNAR1, IFNAR2 💬 D04554 💬 Interferon beta-1a 4件: 13, 26, 96, 97 💬
51 Cytokine-cytokine receptor interaction 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
52 Dilated cardiomyopathy 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
53 Dopaminergic synapse 💬
 3件: PPP3CA, PPP3CB, PPP3CC 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
54 Epstein-Barr virus infection 💬
 2件: IFNAR1, IFNAR2 💬 D03305 💬 Interferon alfa 6件: 13, 25, 26, 28, 56, 96 💬
55 Epstein-Barr virus infection 💬
 2件: IFNAR1, IFNAR2 💬 D04554 💬 Interferon beta-1a 4件: 13, 26, 96, 97 💬
56 Epstein-Barr virus infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
57 Estrogen signaling pathway 💬
 1件: RARA 💬 D01418 💬 Tamibarotene 2件: 26, 96 💬
58 Fc epsilon RI signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
59 Fluid shear stress and atherosclerosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
60 GABAergic synapse 💬
 3件: ABAT, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
61 Gap junction 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 3件: 26, 34, 331 💬
62 Gap junction 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 3件: 26, 34, 331 💬
63 Gastric acid secretion 💬
 1件: CHRM3 💬 D00481 💬 Propantheline 1件: 26 💬
64 Glucagon signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
65 Glutamatergic synapse 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
66 GnRH secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
67 Graft-versus-host disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
68 Hematopoietic cell lineage 💬
 1件: CSF3R 💬 D03235 💬 Filgrastim 33件:  2 ,  6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
69 Hematopoietic cell lineage 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
70 Hepatitis B 💬
 1件: IFNAR1 💬 D03305 💬 Interferon alfa 6件: 13, 25, 26, 28, 56, 96 💬
71 Hepatitis B 💬
 1件: IFNAR1 💬 D04554 💬 Interferon beta-1a 4件: 13, 26, 96, 97 💬
72 Hepatitis B 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
73 Hepatitis C 💬
 2件: IFNAR1, IFNAR2 💬 D03305 💬 Interferon alfa 6件: 13, 25, 26, 28, 56, 96 💬
74 Hepatitis C 💬
 2件: IFNAR1, IFNAR2 💬 D04554 💬 Interferon beta-1a 4件: 13, 26, 96, 97 💬
75 Hepatitis C 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
76 Herpes simplex virus 1 infection 💬
 2件: IFNAR1, IFNAR2 💬 D03305 💬 Interferon alfa 6件: 13, 25, 26, 28, 56, 96 💬
77 Herpes simplex virus 1 infection 💬
 2件: IFNAR1, IFNAR2 💬 D04554 💬 Interferon beta-1a 4件: 13, 26, 96, 97 💬
78 Herpes simplex virus 1 infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
79 Human cytomegalovirus infection 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
80 Human cytomegalovirus infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
81 Human immunodeficiency virus 1 infection 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
82 Human immunodeficiency virus 1 infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
83 Human papillomavirus infection 💬
 2件: IFNAR1, IFNAR2 💬 D03305 💬 Interferon alfa 6件: 13, 25, 26, 28, 56, 96 💬
84 Human papillomavirus infection 💬
 2件: IFNAR1, IFNAR2 💬 D04554 💬 Interferon beta-1a 4件: 13, 26, 96, 97 💬
85 Human papillomavirus infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
86 Human T-cell leukemia virus 1 infection 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
87 Human T-cell leukemia virus 1 infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
88 Huntington disease 💬
 1件: PSMB5 💬 D03150 💬 Bortezomib 15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
89 Huntington disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 3件: 26, 34, 331 💬
90 Huntington disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 3件: 26, 34, 331 💬
91 Hypertrophic cardiomyopathy 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
92 IL-17 signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
93 Inflammatory bowel disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
94 Influenza A 💬
 2件: IFNAR1, IFNAR2 💬 D03305 💬 Interferon alfa 6件: 13, 25, 26, 28, 56, 96 💬
95 Influenza A 💬
 2件: IFNAR1, IFNAR2 💬 D04554 💬 Interferon beta-1a 4件: 13, 26, 96, 97 💬
96 Influenza A 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
97 Insulin resistance 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
98 Insulin secretion 💬
 1件: CHRM3 💬 D00481 💬 Propantheline 1件: 26 💬
99 JAK-STAT signaling pathway 💬
 1件: CSF3R 💬 D03235 💬 Filgrastim 33件:  2 ,  6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
100 JAK-STAT signaling pathway 💬
 2件: IFNAR1, IFNAR2 💬 D03305 💬 Interferon alfa 6件: 13, 25, 26, 28, 56, 96 💬
101 JAK-STAT signaling pathway 💬
 2件: IFNAR1, IFNAR2 💬 D04554 💬 Interferon beta-1a 4件: 13, 26, 96, 97 💬
102 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: CCR4 💬 D09761 💬 Mogamulizumab 1件: 26 💬
103 Kaposi sarcoma-associated herpesvirus infection 💬
 2件: IFNAR1, IFNAR2 💬 D03305 💬 Interferon alfa 6件: 13, 25, 26, 28, 56, 96 💬
104 Kaposi sarcoma-associated herpesvirus infection 💬
 2件: IFNAR1, IFNAR2 💬 D04554 💬 Interferon beta-1a 4件: 13, 26, 96, 97 💬
105 Kaposi sarcoma-associated herpesvirus infection 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
106 Legionellosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
107 Leishmaniasis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
108 Long-term potentiation 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
109 Malaria 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
110 MAPK signaling pathway 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
111 MAPK signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
112 MAPK signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
113 Measles 💬
 2件: IFNAR1, IFNAR2 💬 D03305 💬 Interferon alfa 6件: 13, 25, 26, 28, 56, 96 💬
114 Measles 💬
 2件: IFNAR1, IFNAR2 💬 D04554 💬 Interferon beta-1a 4件: 13, 26, 96, 97 💬
115 Metabolic pathways 💬
 4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
116 mTOR signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
117 Natural killer cell mediated cytotoxicity 💬
 2件: IFNAR1, IFNAR2 💬 D03305 💬 Interferon alfa 6件: 13, 25, 26, 28, 56, 96 💬
118 Natural killer cell mediated cytotoxicity 💬
 2件: IFNAR1, IFNAR2 💬 D04554 💬 Interferon beta-1a 4件: 13, 26, 96, 97 💬
119 Natural killer cell mediated cytotoxicity 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
120 Natural killer cell mediated cytotoxicity 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
121 Necroptosis 💬
 2件: IFNAR1, IFNAR2 💬 D03305 💬 Interferon alfa 6件: 13, 25, 26, 28, 56, 96 💬
122 Necroptosis 💬
 2件: IFNAR1, IFNAR2 💬 D04554 💬 Interferon beta-1a 4件: 13, 26, 96, 97 💬
123 Necroptosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
124 Neuroactive ligand-receptor interaction 💬
 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 D00481 💬 Propantheline 1件: 26 💬
125 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D00407 💬 Methylprednisolone 44件:  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
126 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D00751 💬 Methylprednisolone 44件:  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
127 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D00979 💬 Methylprednisolone 44件:  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
128 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D05000 💬 Methylprednisolone 44件:  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
129 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D05001 💬 Methylprednisolone 44件:  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
130 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D05002 💬 Methylprednisolone 44件:  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
131 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D00472 💬 Prednisolone 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
132 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D00980 💬 Prednisolone 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
133 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D00981 💬 Prednisolone 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
134 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D00982 💬 Prednisolone 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
135 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D01239 💬 Prednisolone 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
136 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D01998 💬 Prednisolone 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
137 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D02156 💬 Prednisolone 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
138 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D03301 💬 Prednisolone 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
139 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D00473 💬 Prednisone 47件:  2 ,  6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬
140 NF-kappa B signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
141 NOD-like receptor signaling pathway 💬
 2件: IFNAR1, IFNAR2 💬 D03305 💬 Interferon alfa 6件: 13, 25, 26, 28, 56, 96 💬
142 NOD-like receptor signaling pathway 💬
 2件: IFNAR1, IFNAR2 💬 D04554 💬 Interferon beta-1a 4件: 13, 26, 96, 97 💬
143 NOD-like receptor signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
144 Non-alcoholic fatty liver disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
145 Oocyte meiosis 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
146 Osteoclast differentiation 💬
 2件: IFNAR1, IFNAR2 💬 D03305 💬 Interferon alfa 6件: 13, 25, 26, 28, 56, 96 💬
147 Osteoclast differentiation 💬
 2件: IFNAR1, IFNAR2 💬 D04554 💬 Interferon beta-1a 4件: 13, 26, 96, 97 💬
148 Osteoclast differentiation 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
149 Osteoclast differentiation 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
150 Oxytocin signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
151 Pancreatic secretion 💬
 1件: CHRM3 💬 D00481 💬 Propantheline 1件: 26 💬
152 Parkinson disease 💬
 1件: PSMB5 💬 D03150 💬 Bortezomib 15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
153 Parkinson disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 3件: 26, 34, 331 💬
154 Parkinson disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 3件: 26, 34, 331 💬
155 Pathogenic Escherichia coli infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
156 Pathogenic Escherichia coli infection 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 3件: 26, 34, 331 💬
157 Pathogenic Escherichia coli infection 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 3件: 26, 34, 331 💬
158 Pathways in cancer 💬
 1件: CSF3R 💬 D03235 💬 Filgrastim 33件:  2 ,  6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
159 Pathways in cancer 💬
 2件: IFNAR1, IFNAR2 💬 D03305 💬 Interferon alfa 6件: 13, 25, 26, 28, 56, 96 💬
160 Pathways in cancer 💬
 2件: IFNAR1, IFNAR2 💬 D04554 💬 Interferon beta-1a 4件: 13, 26, 96, 97 💬
161 Pathways in cancer 💬
 1件: RARA 💬 D01418 💬 Tamibarotene 2件: 26, 96 💬
162 Pathways of neurodegeneration - multiple diseases 💬
 3件: CHRM1, CHRM3, CHRM5 💬 D00481 💬 Propantheline 1件: 26 💬
163 Pathways of neurodegeneration - multiple diseases 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
164 Pathways of neurodegeneration - multiple diseases 💬
 1件: PSMB5 💬 D03150 💬 Bortezomib 15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
165 Pathways of neurodegeneration - multiple diseases 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
166 Pathways of neurodegeneration - multiple diseases 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 3件: 26, 34, 331 💬
167 Pathways of neurodegeneration - multiple diseases 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 3件: 26, 34, 331 💬
168 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: PDCD1 💬 D10316 💬 Nivolumab 12件: 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
169 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
170 Pertussis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
171 Phagosome 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 3件: 26, 34, 331 💬
172 Phagosome 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 3件: 26, 34, 331 💬
173 PI3K-Akt signaling pathway 💬
 2件: CHRM1, CHRM2 💬 D00481 💬 Propantheline 1件: 26 💬
174 PI3K-Akt signaling pathway 💬
 1件: CSF3R 💬 D03235 💬 Filgrastim 33件:  2 ,  6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
175 PI3K-Akt signaling pathway 💬
 2件: IFNAR1, IFNAR2 💬 D03305 💬 Interferon alfa 6件: 13, 25, 26, 28, 56, 96 💬
176 PI3K-Akt signaling pathway 💬
 2件: IFNAR1, IFNAR2 💬 D04554 💬 Interferon beta-1a 4件: 13, 26, 96, 97 💬
177 Platinum drug resistance 💬
 2件: TOP2A, TOP2B 💬 D03899 💬 Doxorubicin 4件: 26, 28, 34, 331 💬
178 Platinum drug resistance 💬
 2件: TOP2A, TOP2B 💬 D00125 💬 Etoposide 11件: 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬
179 Platinum drug resistance 💬
 2件: TOP2A, TOP2B 💬 D04107 💬 Etoposide 11件: 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬
180 Prion disease 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
181 Prion disease 💬
 1件: PSMB5 💬 D03150 💬 Bortezomib 15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
182 Prion disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
183 Prion disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 3件: 26, 34, 331 💬
184 Prion disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 3件: 26, 34, 331 💬
185 Propanoate metabolism 💬
 1件: ABAT 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
186 Proteasome 💬
 1件: PSMB5 💬 D03150 💬 Bortezomib 15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
187 Proteoglycans in cancer 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
188 Regulation of actin cytoskeleton 💬
 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 D00481 💬 Propantheline 1件: 26 💬
189 Renin secretion 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
190 Rheumatoid arthritis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
191 RIG-I-like receptor signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
192 Salivary secretion 💬
 1件: CHRM3 💬 D00481 💬 Propantheline 1件: 26 💬
193 Salmonella infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
194 Salmonella infection 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 3件: 26, 34, 331 💬
195 Salmonella infection 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 3件: 26, 34, 331 💬
196 Shigellosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
197 Sphingolipid signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
198 Spinocerebellar ataxia 💬
 1件: PSMB5 💬 D03150 💬 Bortezomib 15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
199 Systemic lupus erythematosus 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
200 T cell receptor signaling pathway 💬
 1件: PDCD1 💬 D10316 💬 Nivolumab 12件: 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
201 T cell receptor signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
202 T cell receptor signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
203 Taste transduction 💬
 1件: CHRM3 💬 D00481 💬 Propantheline 1件: 26 💬
204 Taurine and hypotaurine metabolism 💬
 2件: GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
205 TGF-beta signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
206 Th1 and Th2 cell differentiation 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
207 Th17 cell differentiation 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
208 Th17 cell differentiation 💬
 1件: RARA 💬 D01418 💬 Tamibarotene 2件: 26, 96 💬
209 TNF signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
210 Toll-like receptor signaling pathway 💬
 2件: IFNAR1, IFNAR2 💬 D03305 💬 Interferon alfa 6件: 13, 25, 26, 28, 56, 96 💬
211 Toll-like receptor signaling pathway 💬
 2件: IFNAR1, IFNAR2 💬 D04554 💬 Interferon beta-1a 4件: 13, 26, 96, 97 💬
212 Toll-like receptor signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
213 Toxoplasmosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
214 Transcriptional misregulation in cancer 💬
 1件: RARA 💬 D01418 💬 Tamibarotene 2件: 26, 96 💬
215 Tuberculosis 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
216 Tuberculosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
217 Type I diabetes mellitus 💬
 2件: GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
218 Type I diabetes mellitus 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
219 Type II diabetes mellitus 💬
 1件: CACNA1G 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
220 Type II diabetes mellitus 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
221 Valine, leucine and isoleucine degradation 💬
 1件: ABAT 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
222 VEGF signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
223 Viral carcinogenesis 💬
 1件: CCR4 💬 D09761 💬 Mogamulizumab 1件: 26 💬
224 Viral protein interaction with cytokine and cytokine receptor 💬
 1件: CCR4 💬 D09761 💬 Mogamulizumab 1件: 26 💬
225 Viral protein interaction with cytokine and cytokine receptor 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
226 Wnt signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
227 Yersinia infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬

先頭へ